Page last updated: 2024-08-22

gold and tenofovir

gold has been researched along with tenofovir in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Arami, H; Cai, Y; Febo, M; Huang, Z; Nair, M; Raymond, A; Rodriguez, E; Takemura, Y; Tomitaka, A1
Bacchetti, P; Baeten, JM; Cressey, TR; Drain, PK; Gandhi, M; Glidden, DV; King, R; Klinbuayaem, V; Mugo, NR; Ngure, K; Okochi, H; Rodrigues, WC; Siriprakaisil, O; Spinelli, MA; Vincent, M; Wang, G1
Fotooh Abadi, L; Gajbhiye, V; Kulkarni, S; Kumar, P; Paknikar, K1

Other Studies

3 other study(ies) available for gold and tenofovir

ArticleYear
Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment.
    Nanoscale, 2017, Dec-21, Volume: 10, Issue:1

    Topics: Anti-Retroviral Agents; Blood-Brain Barrier; Brain; Cell Line; Drug Delivery Systems; Gold; HIV Infections; Humans; Liposomes; Magnetics; Metal Nanoparticles; Microglia; Multimodal Imaging; Nanomedicine; Tenofovir

2017
Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings.
    AIDS (London, England), 2020, 02-01, Volume: 34, Issue:2

    Topics: Anti-HIV Agents; Chromatography, Liquid; Gold; HIV Infections; Humans; Medication Adherence; Metal Nanoparticles; Point-of-Care Testing; Pre-Exposure Prophylaxis; Tandem Mass Spectrometry; Tenofovir

2020
Tenofovir-tethered gold nanoparticles as a novel multifunctional long-acting anti-HIV therapy to overcome deficient drug delivery-: an in vivo proof of concept.
    Journal of nanobiotechnology, 2023, Jan-19, Volume: 21, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Gold; HIV Infections; Humans; Metal Nanoparticles; Peptide Hydrolases; Tenofovir; Tissue Distribution

2023